Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anisha Solanki

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|September 29, 2015
A genome wide transcriptional model of the complex response to pre-TCR signalling during thymocyte differentiationHemant Sahni, Susan Ross, Alessandro Barbarulo, et al.
The Journal of Clinical Investigation|July 3, 2019
Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulationEleftheria Papaioannou, Diana C Yánez, Susan Ross, et al.
Journal of Medicinal Chemistry|August 18, 2020
Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 PseudokinaseSébastien L Degorce, Omid Tavana, Erica Banks, et al.
EMBO Molecular Medicine|May 5, 2022
A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerabilityElizabeth A Kuczynski, Giulia Morlino, Alison Peter, et al.
European Journal of Immunology|October 27, 2018
IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammationDiana C Yánez, Hemant Sahni, Susan Ross, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancerAlexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.
Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Oncotarget|September 29, 2015
A genome wide transcriptional model of the complex response to pre-TCR signalling during thymocyte differentiationHemant Sahni, Susan Ross, Alessandro Barbarulo, et al.
The Journal of Clinical Investigation|July 3, 2019
Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulationEleftheria Papaioannou, Diana C Yánez, Susan Ross, et al.
Journal of Medicinal Chemistry|August 18, 2020
Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 PseudokinaseSébastien L Degorce, Omid Tavana, Erica Banks, et al.
EMBO Molecular Medicine|May 5, 2022
A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerabilityElizabeth A Kuczynski, Giulia Morlino, Alison Peter, et al.
European Journal of Immunology|October 27, 2018
IFITM proteins drive type 2 T helper cell differentiation and exacerbate allergic airway inflammationDiana C Yánez, Hemant Sahni, Susan Ross, et al.
Journal for Immunotherapy of Cancer|April 7, 2022
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancerAlexey Revenko, Larissa S Carnevalli, Charles Sinclair, et al.
Cancer Cell|July 11, 2025
KEAP1 and STK11/LKB1 alterations enhance vulnerability to ATR inhibition in KRAS mutant non-small cell lung cancerAna Galan-Cobo, Natalie I Vokes, Yu Qian, et al.
Nature Communications|February 24, 2024
The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironmentElizabeth L Hardaker, Emilio Sanseviero, Ankur Karmokar, et al.
Pageof 2